The role played by serical and mucosal IgA responses, the total IgA generation rate from this response, and the involvement of its epitopes in COVID-19 severity and/or vaccination are largely poor explored areas [3,4,23] aside from notable instances such as frequent thromboembolisms in severe COVID-19 cases [24,25,26,27]. This evidence concerns the gene CD79A and COVID-19.